These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1775392)

  • 1. [The immunobiological effects of nitrogranulogen. I. Summarizing the results of the immunological studies to date].
    Górski A; Wasik M; Nowaczyk M; Stepień-Sopniewska B
    Pol Arch Med Wewn; 1991 Aug; 86(2):65-7. PubMed ID: 1775392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogranulogen-dependent inhibition of antibody synthesis. I. In vitro studies in man.
    Wasik M; Stepień-Sopniewska B; Kozakiewicz A; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):117-20. PubMed ID: 1804040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice.
    Lagodziński Z; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):121-5. PubMed ID: 1804041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive drugs inhibit class II antigen (HLA-D) synthesis by B and T lymphocytes.
    Nowaczyk M; Pluta A; Modlińska M; Bukowska J; Górski A
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):415-9. PubMed ID: 2130806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunobiological effects of nitrogranulogen. I. Effect of nitrogranulogen on laboratory and clinical parameters in patients with primary glomerulopathies].
    Rancewicz Z; Imiela J; Juskowa J; Małecki R; Górski A
    Pol Arch Med Wewn; 1991 Aug; 86(2):68-74. PubMed ID: 1775393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrogranulogen: a strong inhibitor of human lymphocyte proliferation.
    Wasik M; Górski A
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):49-54. PubMed ID: 2619509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice.
    Wang YP; Li XY; Song CQ; Hu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):263-6. PubMed ID: 11918853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrogranulogen enhances IL-1 production but decreases cellular sensitivity to this cytokine.
    Stepień-Sopniewska B; Ołdakowska U; Wasik M; Juskowa J; Górski A
    Folia Biol (Praha); 1991; 37(3-4):234-40. PubMed ID: 1822450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro.
    Górski A; Grieb P; Korczak-Kowalska G; Wierzbicki P; Stepień-Sopniewska B; Mrowiec T
    Immunopharmacology; 1993; 26(3):197-202. PubMed ID: 7904595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-dependent lymphocyte apoptosis induced by methotrexate.
    Paillot R; Genestier L; Fournel S; Ferraro C; Miossec P; Revillard JP
    Transplant Proc; 1998 Aug; 30(5):2348-50. PubMed ID: 9723499
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-cancer agents. Curry for cancer?
    TreatmentUpdate; 2000 Jan; 11(10):9. PubMed ID: 12125639
    [No Abstract]   [Full Text] [Related]  

  • 12. [The metabolites of anaerobic bacteria (volatile fatty acids) and the reactivity of the macroorganism].
    Belborodova NV; Beloborodov SM
    Antibiot Khimioter; 2000; 45(2):28-36. PubMed ID: 10707804
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro immunomodulatory activity of ruthenium complexes.
    Newcomb JR; Rivnay B; Bastos CM; Ocain TD; Gordon K; Gregory P; Turci SM; Sterne KA; Jesson M; Krieger J; Jenson JC; Jones B
    Inflamm Res; 2003 Jun; 52(6):263-71. PubMed ID: 12835898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 16. [T- and B-lymphocytes].
    Petrov RV; Cheredeev AN
    Usp Sovrem Biol; 1974; 77(1):90-105. PubMed ID: 4619259
    [No Abstract]   [Full Text] [Related]  

  • 17. The unique immunosuppressive activity of brequinar sodium.
    Jaffee BD; Jones EA; Loveless SE; Chen SF
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):19-22. PubMed ID: 7685954
    [No Abstract]   [Full Text] [Related]  

  • 18. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tetrachloroethylene on hepatic and splenic lymphocytotoxic activities in rodents.
    Schlichting LM; Wright PF; Stacey NH
    Toxicol Ind Health; 1992; 8(5):255-66. PubMed ID: 1455436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.